ALB and metastatic malignant neoplasm in the lymph nodes: These factors included age (≥50/60 years), gender (male vs. female), Eastern Cooperative Oncology Group (ECOG) performance status (≥1), multifocal tumor (yes vs. no), tumor location (bilobar vs. unilobar), largest tumor size (>5/10 cm), carbohydrate antigen 19-9 (CA 19-9) levels (elevated levels), CEA levels (>5 ng/mL), TNM stage (stage ≥3), vascular invasion (yes vs. no), lymph node metastasis (yes vs. no), Child-Pugh class (B vs. A), albumin (ALB) levels (<35 g/L vs. >35 g/L), and HBV status (positive vs. negative).